TransEnterix, Inc. (TRXC): Price and Financial Metrics


TransEnterix, Inc. (TRXC): $4.08

-0.46 (-10.13%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

TRXC Stock Summary

  • TRXC's price/sales ratio is 147.91; that's higher than the P/S ratio of 97.28% of US stocks.
  • Revenue growth over the past 12 months for Transenterix Inc comes in at -82.07%, a number that bests merely 1.67% of the US stocks we're tracking.
  • In terms of volatility of its share price, TRXC is more volatile than 99.43% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Transenterix Inc, a group of peers worth examining would be GNMK, DMRC, PSTG, RDFN, and GKOS.
  • TRXC's SEC filings can be seen here. And to visit Transenterix Inc's official web site, go to www.transenterix.com.

TRXC Stock Price Chart Interactive Chart >

Price chart for TRXC

TRXC Price/Volume Stats

Current price $4.08 52-week high $6.95
Prev. close $4.54 52-week low $0.28
Day low $3.62 Volume 37,554,301
Day high $4.77 Avg. volume 44,558,918
50-day MA $3.04 Dividend yield N/A
200-day MA $1.09 Market Cap 582.53M

TransEnterix, Inc. (TRXC) Company Bio


TransEnterix, Inc. focuses on the development and commercialization of a robotic assisted surgical system in the United States and internationally. The company is based in Morrisville, North Carolina.


TRXC Latest News Stream


Event/Time News Detail
Loading, please wait...

TRXC Latest Social Stream


Loading social stream, please wait...

View Full TRXC Social Stream

Latest TRXC News From Around the Web

Below are the latest news stories about Transenterix Inc that investors may wish to consider to help them evaluate TRXC as an investment opportunity.

Asensus Surgical, Inc. Schedules Fourth Quarter and Fiscal Year 2020 Financial and Operating Results Conference Call for March 11, 2021

Asensus Surgical, Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release fourth quarter and fiscal year 2020 financial and operating results after the market closes on Thursday, March 11, 2021. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day. The call will be concurrently webcast.

Yahoo | March 4, 2021

Asensus Surgical Announces FDA Clearance in General Surgery

Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: TRXC) , a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced the Company has received an additional FDA clearance for the Senhance Surgical System which allows for indication expansion in general surgery in the United States.

Yahoo | March 3, 2021

TransEnterix (TRXC) Flat As Market Gains: What You Should Know

TransEnterix (TRXC) closed at $3.72 in the latest trading session, marking no change from the prior day.

Yahoo | March 1, 2021

Asensus Surgical to Present at the H.C. Wainwright Virtual Global Life Sciences Conference

Asensus Surgical, Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery, announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the H.C. Wainwright Virtual Global Life Sciences Conference taking place March 9 and March 10, 2021.

Yahoo | March 1, 2021

Is TransEnterix a Good Stock to Buy Now?

Shares of the robotic surgical-system manufacturer are soaring, but can this company become the next Intuitive Surgical?

Yahoo | February 27, 2021

Read More 'TRXC' Stories Here

TRXC Price Returns

1-mo N/A
3-mo N/A
6-mo 37.84%
1-year 788.70%
3-year -93.89%
5-year -76.75%
YTD 552.80%
2020 -57.48%
2019 -95.00%
2018 17.10%
2017 48.46%
2016 -47.58%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8145 seconds.